Refine
Has Fulltext
- yes (9)
Is part of the Bibliography
- yes (9)
Document Type
- Journal article (9)
Language
- English (9)
Keywords
- DNA (1)
- DNA binding (1)
- DNA sequencing (1)
- DPF3a (1)
- Epidermis (1)
- Ethanol (1)
- Glutathione (1)
- HEY repressors (1)
- Hormesis (1)
- Hydrogen-peroxide (1)
- In-vitro (1)
- Metabolism (1)
- Methylation (1)
- Nrf2 (1)
- Oxidative stress (1)
- Oxygen (1)
- PARROT (1)
- Polyphenols (1)
- RNA (1)
- RNA-binding proteins (1)
- ROS (1)
- Redox environment (1)
- Skin (1)
- TLR agonists (1)
- Trans-reservatrol (1)
- Transferases (1)
- body weight regulation (1)
- c-Myc (1)
- cancer vaccines (1)
- cardiac hypertrophy (1)
- colorectal cancer (1)
- dendritic cells (1)
- genes (1)
- glucocorticoid receptor (1)
- human cell nucleus (1)
- iberis amara extract (1)
- long ncRNA (1)
- phosphorylation (1)
- prevention (1)
- prostaglandin E2 (1)
- serial RNA interactome capture (1)
- targeted re-sequencing (1)
- transcription factors (1)
- treatment (1)
- tumor-specific CD8+ T cells (1)
- upstream regulator (1)
Institute
Mature dendritic cells (DCs) represent cellular adjuvants for optimal antigen presentation in cancer vaccines. Recently, a combination of prostaglandin E\(_2\) (PGE\(_2\)) with Toll-like receptor agonists (TLR-P) was proposed as a new standard to generate superior cytokine-producing DCs with high migratory capacity. Here, we compare TLR-P DCs with conventional DCs matured only with the proinflammatory cytokines TNFα and IL-1ß (CDCs), focussing on the interaction of resulting DCs with CD8\(^+\) T-cells. TLR-P matured DCs showed elevated expression of activation markers such as CD80 and CD83 compared to CDCs, together with a significantly higher migration capacity. Secretion of IL-6, IL-8, IL-10, and IL-12 was highest after 16 h in TLR-P DCs, and only TLR-P DCs secreted active IL-12p70. TLR-P DCs as well as CDCs successfully primed multifunctional CD8\(^+\) T-cells from naïve precursors specific for the peptide antigens Melan-A, NLGN4X, and PTP with comparable priming efficacy and T-cell receptor avidity. CD8\(^+\) T-cells primed by TLR-P DCs showed significantly elevated expression of the integrin VLA-4 and a trend for higher T-cell numbers after expansion. In contrast, TLR-P DCs displayed a substantially reduced capability to cross-present CMVpp65 protein antigen to pp65-specific T cells, an effect that was dose-dependent on PGE2 during DC maturation and reproducible with several responder T-cell lines. In conclu-sion, TLR-P matured DCs might be optimal presenters of antigens not requiring processing such as short peptides. However, PGE\(_2\) seems less favorable for maturation of DCs intended to process and cross-present more complex vaccine antigens such as lysates, proteins or long peptides.